| 1 |
32506993 | Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling. | 2020 Aug |
1 |
| 2 |
31273323 | Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects. | 2019 Sep |
2 |
| 3 |
28543186 | Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome. | 2018 Apr |
2 |
| 4 |
27012748 | Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells. | 2016 Jun |
2 |
| 5 |
27547594 | Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome. | 2016 Apr |
3 |
| 6 |
23034980 | Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes. | 2013 Oct |
2 |
| 7 |
21695018 | The role of fatty aldehyde dehydrogenase in epidermal structure and function. | 2011 Apr |
1 |
| 8 |
18035827 | Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome. | 2007 Oct |
2 |
| 9 |
15834613 | Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome. | 2005 Jun |
2 |